Corrigendum to "Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial" [J Infect 84(6) (2022) 795-813, 5511]
1 Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
2 NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.
3 Imperial Clinical Trials Unit, Imperial College London, London, UK.
4 Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre, Oxford, UK.
5 NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
6 Stockport NHS Foundation Trust, Stockport, UK.
7 NIHR Liverpool and Broadgreen Clinical Research Facility, Liverpool, UK.
8 NIHR Cambridge Clinical Research Facility, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
9 Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
10 PHARMExcel, Welwyn Garden City, Hertfordshire, UK.
11 NIHR/Wellcome Clinical Research Facility, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
12 Department of Infection, Guy's and St Thomas' NHS Foundation Trust, London, UK; MRC Clinical Trials Unit, University College London, London, UK.
13 Portsmouth Hospitals University NHS Trust, Portsmouth, UK.
14 Queen Elizabeth University Hospital, NHS Greater Glasgow & Clyde, Glasgow, UK.
15 Wellcome-MRC Institute of Metabolic Science, Department of Clinical Biochemistry, University of Cambridge, Cambridge, UK.
16 Cancer Research UK Oxford Centre, University of Oxford, Oxford, UK.
17 NIHR UCLH Clinical Research Facility and NIHR UCLH Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK.
18 University Hospitals Sussex NHS Foundation Trust, Brighton, UK.
19 Department of Infectious Diseases and Tropical Medicine, London Northwest University Healthcare, London, UK.
20 Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
21 The Adam Practice, Poole, UK.
22 NIHR Oxford Biomedical Research Centre, Oxford, UK.
23 NIHR Leeds Clinical Research Facility, Leeds Teaching Hospitals Trust and University of Leeds, Leeds, UK.
24 Public Health Wales, Betsi Cadwaladr University Health Board, Bangor University, Bangor, UK.
25 University of Liverpool, Liverpool, UK.
26 University Hospitals of Leicester NHS Trust, University of Leicester, Leicester, UK.
27 Bradford Institute for Health Research and Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.
28 Department of Infection, Guy's and St Thomas' NHS Foundation Trust, London, UK.
29 Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter, UK.
30 Queen Elizabeth University Hospital, NHS Greater Glasgow & Clyde, Glasgow, UK; MRC University of Glasgow Centre for Virus Research, Glasgow, UK.
31 UK Health Security Agency, Porton Down, UK.
32 UK Health Security Agency, Colindale, London, UK.
33 Division of Epidemiology and Public Health, University of Nottingham School of Medicine, UK.
34 NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK. Electronic address: [email protected].